Nanostructured Drug Market – Size, Share, Outlook, and Opportunity Analysis

Nanotechnology is an emerging field of science that involves atomic or molecular level manipulation of matter. A nanometer is equals to 1 billionth of a meter. Nanotechnology has various application in different fields such as chemical sensors, batteries, food, fuel cells, solar cells, fabric, fuels, electronics, space, better air quality, cleaner water, and sporting goods. One of the key application of nanotechnology is in medicine, nano-medicine ranges from the medical application such as biological device, nanomaterial, nanoelectronic biosensors, and biological machines. Nanotechnology has presented the option of drug delivery to specific target cells employing nanoparticles. Particles are engineered to attach to diseases cells, which allows of direct treatment of those cells. Drug delivery techniques are designed to reduce the side effects associated with the drugs along with decrease in its consumption and treatment costs. Nanostructured drugs have various applications such as in neurology, cardiovascular/physiology, anti-inflammatory/ immunology, anti-infective, and others.
Request TOC of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1841

Nanostructured Drug Market Dynamics

Nanostructured drugs are gaining significant traction in research and development due to the benefits offered by them in terms of bioavailability, drug stability, shelf-life and dosage. Effective and safe drug delivery is a major challenge in biotechnology and pharmaceutical manufacturers. Novel techniques such as nanotechnology are being introduced by companies to produce innovative product, which is driving growth of the nanostructured drug market. For instance, in 2015, the Food and Drug Administration (FDA) approved Onivyde, an irinotecan liposome injection by merrimack pharmaceuticals, which is a prescription medicine used to treat pancreatic cancer. Onivyde is administered in combination with two other drugs, leucovorin and fluorouracil. Onivyde consists of a chemotherapy drug called irinotecan, which interrupts cell reproduction. Irinotecan is trapped into a nanostructure called liposome. Liposomes are programmed to release drug slowly within the interval of time.

Moreover, increased funding and revenue from nano-enabled products have propelled growth of nanostructured drug market. For instance, According to the National Science Foundation 2014 market report, the global funding for emerging nanotechnology increased by 40% to 45% for past three years. Furthermore, worldwide revenue generated by nano-enabled products have been increased from US$ 339 billion in 2010 to US$ 731 billion in 2012, and to more than US$1 trillion in 2013.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1841

Nanostructured Drug Market – Regional Insights

Based on the region, the global nanostructured drug treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global nanostructured drug market, owing to massive funding by the government for the nanotechnology research. For instance, According to a study led by Lux Research with funding support from U.S. national Foundation and U.S. National Nanotechnology Coordination Office in 2013, around US$ 1.9 billion was funded in 2011 and US$ 2.1 billion in 2012 for nanotechnology research and development (R&D). Moreover, increasing awareness among the population regarding various chronic diseases and well established healthcare infrastructure is expected to propel the nanostructured drug market growth over the forecast period.

Nanostructured Drug Market Taxonomy

On the basis of technology, the global nanostructured drug market is segmented into: Nanoparticles, Nanocrystals, Nanotubes, Liposomes, Micelles, Others,.

On the basis of application, the global nanostructured drug market is segmented into: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others,.

On the basis of geography, the global nanostructured drug market is segmented into: North America, Latin America, Europe, Asia Pacific, Middle East, Africa,.

Access Full Summary at: https://www.coherentmarketinsights.com/ongoing-insight/nanostructured-drug-market-1841

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.